295 results
6-K
EX-99.1
GMAB
Genmab
2 May 24
Genmab Announces Financial Results for the First Quarter of 2024
11:08am
is provided in the following section, including updates for the first quarter of 2024. Detailed descriptions of dosing, efficacy and safety data from … -development with partners as indicated.
2Refer to relevant local prescribing information for precise indication and safety information.
Pipeline
6-K
EX-99.1
GMAB
Genmab
29 Apr 24
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
7:10pm
among these patients and a manageable safety profile with tisotumab vedotin,” said Brian Slomovitz, M.D., Director of Gynecologic Oncology and Co-Chair … data.”
The safety profile of TIVDAK in innovaTV 301 was consistent with its known safety profile as presented in the U.S. prescribing information
6-K
EX-99.1
GMAB
Genmab
29 Apr 24
Current report (foreign)
10:22am
of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our
6-K
EX-99.1
GMAB
Genmab
22 Apr 24
Current report (foreign)
4:14pm
to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market
6-K
EX-99.1
GMAB
Genmab
16 Apr 24
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
10:07am
related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack
6-K
EX-99.1
weg5ikw3bxjl4mfdafy6
15 Apr 24
Current report (foreign)
1:17pm
6-K
EX-99.1
bxdajz
8 Apr 24
Current report (foreign)
1:41pm
6-K
EX-99.1
kabhvo1k
3 Apr 24
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
6:19am
6-K
EX-99.1
zc70b imrx
2 Apr 24
Current report (foreign)
9:10am
6-K
EX-99.1
ontc5xwl
25 Mar 24
Current report (foreign)
2:13pm
6-K
EX-99.1
jmezra
18 Mar 24
Completion of share buy-back program
4:37pm
6-K
EX-99.1
gr5030 4lb2ik
15 Mar 24
Genmab Announces Initiation of Share Buy-Back Program
9:46am
6-K
EX-99.2
8aek9g q8sd
13 Mar 24
Current report (foreign)
5:10pm
6-K
EX-99.1
ry5lqov qd
13 Mar 24
Current report (foreign)
5:10pm
6-K
EX-99.1
4nybyhdiwdn8upodf
13 Mar 24
Passing of Genmab A/S’ Annual General Meeting
11:34am
6-K
EX-99.1
2kxunsm7pwiciplclx
11 Mar 24
Current report (foreign)
1:43pm
6-K
EX-99.1
asr2ndvr
4 Mar 24
Current report (foreign)
1:50pm
6-K
EX-99.1
gqlrmdgt
4 Mar 24
Current report (foreign)
1:26pm
6-K
EX-99.1
8fag8pwq7n5x4vw
1 Mar 24
Current report (foreign)
6:38pm
6-K
EX-99.1
spgpm0u g8dmwy60rgfi
29 Feb 24
Current report (foreign)
11:47am